Testing effectiveness (Phase 2)Ended earlyNCT03155932
What this trial is testing
Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Participants With Primary Biliary Cholangitis
Who this might be right for
Primary Biliary Cholangitis
Arena Pharmaceuticals 2